08.30 – 10.15
The Gulf Brugada Registry: presentation and clinical outcomes
S. Alkaabi/ Abu Dhabi, UAE
10.45 – 12.30
Brugada Syndrome: understanding the role of ”mutation” in 2015
A.A. Wilde/ Amsterdam, The Netherlands
Brugada Syndrome: understanding diagnostic tests and who is at risk?
A.D. Krahn/ Vancouver, Canada
Variants of Brugada Syndrome: the evolving picture
W. Shimizu/ Tokyo, Japan
Drug-induced Brugada Syndrome: clinical and therapeutic implications
P.G. Postema/ Amsterdam, The Netherlands
12.30 – 14.00
State of the art in morphology mapping during VT ablation
M.M. Oliveira/ Lisbon, Portugal
14.00 – 15.45
Congenital long QT syndrome: how should we diagnose it in 2015?
M.J. Ackerman/ Rochester, USA
Should we treat all asymptomatic patients with long QT syndrome?
A.A. Wilde/ Amsterdam, The Netherlands
Drug-induced long QT syndrome: do we understand it in 2015?
M.M. Scheinman/ San Francisco, USA
AV block and torsade de pointes: who is at risk?
R. Rosso/ Tel Aviv, Israel
16.15 – 18.00
Mapping and ablation of ventricular tachycardia in non-ischemic cardiomyopathy
C. Narasimhan / Hyderabad, India
Ventricular arrhythmia in ARVC: mechanisms and management
H. Tandri/ Baltimore, USA